News
Latest News
Consultation: Kava Pilot Phase 2: Allowing the commercial importation of kava
23 March 2020
The Department of Health is seeking comments from interested parties on the options proposed for the commercial importation of kava into Australia. Closing date: 4 May 2020
Consultation: Medicinal Cannabis Cost Recovery Framework
13 March 2020
The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020
Summary of licences granted
3 February 2020
Update to summary of licences granted
Health Products Regulation Group: Regulatory Science Strategy, 2020-2025
16 January 2020
Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
Implementation of the Review of the Narcotic Drugs Act 1967 (Cth)
17 December 2019
The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967
Import restrictions: Kava and Khat
17 December 2019
The travel allowance for kava has now increased from 2kg to 4kg
Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967
5 September 2019
Professor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
Manufacturing licensing and GMP - medicinal cannabis
15 August 2019
Updated guidance on Narcotic Manufacture licences and GMP
Boosting Australia's medicinal cannabis industry
2 August 2019
The Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.
Hemp products
5 July 2019
Update to information for the import of hemp products